Reports for RISPERIDONE
Ingredient
RISPERIDONE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-04-10 | 2020-06-09 | 6340 |
| ACT RISPERIDONE | 1MG | TABLET | Resolved | 2017-03-17 | 2017-09-19 | 3330 |
| ACT RISPERIDONE | 3MG | TABLET | Resolved | 2017-03-17 | 2017-09-19 | 3337 |
| APO-RISPERIDONE | 1MG | SOLUTION | Resolved | 2017-12-14 | 2018-02-14 | 32834 |
| APO-RISPERIDONE | 1MG | SOLUTION | Resolved | 2018-03-27 | 2018-05-15 | 44114 |
| MAR-RISPERIDONE | 2.0MG | TABLET | Resolved | 2018-05-02 | 2018-08-21 | 47994 |
| MAR-RISPERIDONE | 3.0MG | TABLET | Resolved | 2018-05-02 | 2018-08-21 | 47997 |
| MAR-RISPERIDONE | 4.0MG | TABLET | Resolved | 2017-03-13 | 2018-08-21 | 793 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |
| PMS-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118156 |
| PMS-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118159 |
| PMS-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118150 |
| PMS-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118153 |
| RISPERDAL ORAL SOLUTION | 1MG | SOLUTION | To be discontinued | 2023-04-27 | 2023-04-27 | 190894 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2018-09-08 | 2018-09-08 | 60753 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |